塔利多米德对不同类型的β-血病的临床疗效
Wei-Jia Yang1, Qing-Ping Kang2, Qian Zhou2
1Department of Eugenics and Genetics, Guilin People's Hospital, No. 12 of Wenming Road, Xiangshan District, Guilin, Guangxi Province, 541002, China. weijiayangywj@126.com.
BMC medical genomics
|July 18, 2024
概括
在大多数患者中,thalidomide有效治疗β-thalassemia,总体响应率为91.7%. 特定的基因组合预测敏感性,并且药物有助于减少铁过载,当与铁去除疗法相结合时.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- β-thalassemia是一种遗传性血液疾病,需要终身治疗.
- 铁过载是β-血病治疗的常见并发症.
- 不同β-thalassemia基因型的thalidomide的疗效尚未完全理解.
研究的目的:
- 为了研究thalidomide在各种β-thalassemia基因型中的疗效.
- 为了确定thalidomide敏感的血病病例,以便进行早期查.
- 评估thalidomide对铁过载的影响.
主要方法:
- 一项为期两年的研究,包括48名β-血病患者 (34名TDT,14名NTDT) 接受了thalidomide治疗.
- 监测血红蛋白 (Hb),胎儿血红蛋白 (HbF) 和血清铁素 (SF) 的水平.
- 根据血液输血量和SF水平的Hb增加和减少来评估治疗反应.
主要成果:
- 总体响应率 (ORR) 为91.7% (44/48),其中72.9%实现主要响应 (MaR).
- 输血依赖性沙拉西米亚 (TDT) 患者的输血量减少了31.3%,61.8%的患者变得不依赖于输血.
- 观察到Hb,HbF和SF水平的显著改善,特别是在具有特定基因组合的患者中.
结论:
- 十个对thalidomide敏感的β-thalassemia基因组合被确定用于临床查.
- thalidomide在β-thalassemia中显示出显著的治疗疗效.
- 将thalidomide与去除铁的疗法相结合,可以改善铁过载的管理.
更多相关视频
相关概念视频
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
430
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
430
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Multiple Allele Traits
34.1K
The Concept of Multiple Allelism
34.1K


